Following the Biden administration’s progress towards lowering prescription drug prices with Medicare price negotiations, some industry advocates want Congress to go a step farther and close patent loopholes which prevent generic varieties of top-selling drugs. “What we’ve been seeing lately is that companies are filing for dozens or even hundreds of patents to extend their monopoly period in order to keep their revenues, and that’s blocking competition from the market,” Priti Krishtel, co-founder of medicine access nonprofit I-MAK, said. Patents give companies 20 years of manufacturing exclusivity on their drugs, designed to allow pharmaceutical companies to recoup development cost
Hence then, the article about patent system key to lower drug prices experts say was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Patent system key to lower drug prices, experts say )